Literature DB >> 15026149

A lamin A/C beta-strand containing the site of lipodystrophy mutations is a major surface epitope for a new panel of monoclonal antibodies.

Sushila Manilal1, K Natalie Randles, Christelle Aunac, Man thi Nguyen, Glenn E Morris.   

Abstract

Using a phage-displayed peptide library, we have identified the epitope recognized by a new panel of five monoclonal antibodies (mAbs) raised against full-length recombinant human lamin A. The mAbs were found to recognize both lamin A and C by Western blotting and immunolocalization at the nuclear rim. A nine-amino acid consensus sequence PLLTYRFPP in the common immunoglobulin-like (Ig-like) domain of lamin A/C contains the binding site for all five mAbs. Three-dimensional structure of the Ig-like domain of lamin A/C shows this sequence is a complete beta-strand. This sequence includes arginine-482 (R482) which is mutated in most cases of Dunnigan-type familial partial lipodystrophy (FPLD). R482 may be part of an interaction site on the surface of lamin A/C for lamin-binding proteins associated with lipodystrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026149     DOI: 10.1016/j.bbagen.2004.01.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Lamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy.

Authors:  Darija Šoltić; Hannah K Shorrock; Hazel Allardyce; Emma L Wilson; Ian Holt; Silvia A Synowsky; Sally L Shirran; Simon H Parson; Thomas H Gillingwater; Heidi R Fuller
Journal:  Hum Mol Genet       Date:  2019-11-01       Impact factor: 6.150

2.  Poly C Binding Protein 2 dependent nuclear retention of the utrophin-A mRNA in C2C12 cells.

Authors:  Gargi Ghosh; Satyabrata Samui; Santanu Das; Vandana Singh; Doel Pal; Subhanwita Das; Jishu Naskar; Soumya Sinha Roy; Utpal Basu
Journal:  RNA Biol       Date:  2021-12-14       Impact factor: 4.652

3.  Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.

Authors:  Yuexia Wang; Andrey A Panteleyev; David M Owens; Karima Djabali; Colin L Stewart; Howard J Worman
Journal:  Hum Mol Genet       Date:  2008-04-28       Impact factor: 6.150

4.  Nesprin-2 accumulates at the front of the nucleus during confined cell migration.

Authors:  Patricia M Davidson; Aude Battistella; Théophile Déjardin; Timo Betz; Julie Plastino; Nicolas Borghi; Bruno Cadot; Cécile Sykes
Journal:  EMBO Rep       Date:  2020-05-17       Impact factor: 8.807

5.  Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.

Authors:  K Natalie Randles; Le Thanh Lam; Caroline A Sewry; Megan Puckelwartz; Denis Furling; Manfred Wehnert; Elizabeth M McNally; Glenn E Morris
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

6.  Nesprin-1-alpha2 associates with kinesin at myotube outer nuclear membranes, but is restricted to neuromuscular junction nuclei in adult muscle.

Authors:  Ian Holt; Heidi R Fuller; Le Thanh Lam; Caroline A Sewry; Sally L Shirran; Qiuping Zhang; Catherine M Shanahan; Glenn E Morris
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

7.  Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W.

Authors:  Marko Roblek; Stefan Schüchner; Veronika Huber; Katrin Ollram; Sylvia Vlcek-Vesely; Roland Foisner; Manfed Wehnert; Egon Ogris
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

8.  Absence of gemin5 from SMN complexes in nuclear Cajal bodies.

Authors:  Le thi Hao; Heidi R Fuller; Le Thanh Lam; Thanh T Le; Arthur H M Burghes; Glenn E Morris
Journal:  BMC Cell Biol       Date:  2007-07-18       Impact factor: 4.241

9.  Differential basal-to-apical accessibility of lamin A/C epitopes in the nuclear lamina regulated by changes in cytoskeletal tension.

Authors:  Teemu O Ihalainen; Lina Aires; Florian A Herzog; Ruth Schwartlander; Jens Moeller; Viola Vogel
Journal:  Nat Mater       Date:  2015-08-24       Impact factor: 43.841

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.